Nipro Diagnostics announced that the Food and Drug Administration (FDA) has granted clearance for its True Metrix Self-Monitoring blood glucose system and the True Metrix Pro Professional Monitoring blood glucose system.
Nipro conducted a study to assess the accuracy of the True Metrix Self-Monitoring and the True Metrix Pro Professional Monitoring blood glucose systems when tested by lay users and health care professionals, respectively. The data showed that the two meter systems exceeded the minimum accuracy criteria for the newer performance requirements for accuracy.
The True Metrix systems feature the Triple Sense Technology that detects, analyzes, and corrects for environmental and physiological variability, including hematocrit and temperature. The meters also feature pre- and post-meal tags that allow patients to mark blood glucose levels to better track how food affects their blood glucose.
Conditions such as exercise, mediation, sickness and other occasions can be tagged to glucose readings in order to monitor patterns and trends for better management.
The True Metrix systems will be available beginning in the fourth quarter of 2014.
For more information call (800) 803-6025 or visit NiproDiagnostics.com.
This article originally appeared on MPR